Alignment Healthcare, Inc. ALHC
We take great care to ensure that the data presented and summarized in this overview for Alignment Healthcare, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding ALHC
View all-
General Atlantic LLC New York, NY44MShares$718 Million21.43% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$217 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD12.3MShares$201 Million0.11% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il8.32MShares$136 Million0.02% of portfolio
-
Black Rock Inc. New York, NY8.19MShares$134 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny6.21MShares$101 Million0.05% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL5.52MShares$90 Million1.25% of portfolio
-
8 Knots Management, LLC Dallas, TX5.02MShares$81.9 Million10.59% of portfolio
-
Invesco Ltd. Atlanta, GA4.17MShares$68.1 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA4.15MShares$67.7 Million0.01% of portfolio
Latest Institutional Activity in ALHC
Top Purchases
Top Sells
About ALHC
Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform. It provides customized health care in the United States to seniors and those who need it through its Medicare advantage plans. The company owns Medicare advantage plans in the states of California, North Carolina, and Nevada. It also coordinates and provides covered health care services, including professional, institutional, and ancillary services to members enrolled in certain benefit plans of unaffiliated Medicare Advantage Health Maintenance Organizations. The company was founded in 2013 and is based in Orange, California.
Insider Transactions at ALHC
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 12
2025
|
General Atlantic LLC Director |
SELL
Open market or private sale
|
Indirect |
13,460,000
-30.38%
|
$215,360,000
$16.01 P/Share
|
|
Sep 12
2025
|
General Atlantic (Aln Hlth), L.P. Director |
SELL
Open market or private sale
|
Indirect |
13,460,000
-30.38%
|
$215,360,000
$16.01 P/Share
|
|
Sep 10
2025
|
Christopher J Joyce Chief Legal and Admin. Officer |
SELL
Open market or private sale
|
Direct |
30,939
-4.2%
|
$495,024
$16.55 P/Share
|
|
Sep 10
2025
|
Dawn Christine Maroney President |
SELL
Open market or private sale
|
Direct |
215,662
-3.69%
|
$3,450,592
$16.5 P/Share
|
|
Sep 10
2025
|
Robert L. Scavo Chief Information Officer |
SELL
Open market or private sale
|
Direct |
29,535
-2.48%
|
$472,560
$16.55 P/Share
|
|
Sep 10
2025
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
180,000
-13.11%
|
$2,880,000
$16.42 P/Share
|
|
Sep 10
2025
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
355,018
-3.69%
|
$5,680,288
$16.55 P/Share
|
|
Sep 09
2025
|
Joseph S Konowiecki Director |
SELL
Open market or private sale
|
Direct |
25,000
-2.17%
|
$425,000
$17.0 P/Share
|
|
Aug 25
2025
|
Andreas P. Wagner Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
12,032
-5.9%
|
$192,512
$16.47 P/Share
|
|
Aug 22
2025
|
Hyong Kim Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
24,800
-5.25%
|
$396,800
$16.0 P/Share
|
|
Aug 13
2025
|
Hyong Kim Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
18,600
-3.79%
|
$279,000
$15.03 P/Share
|
|
Aug 13
2025
|
Dawn Christine Maroney President |
SELL
Open market or private sale
|
Direct |
30,000
-1.47%
|
$420,000
$14.9 P/Share
|
|
Aug 11
2025
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
180,000
-11.59%
|
$2,520,000
$14.6 P/Share
|
|
Aug 11
2025
|
Hyong Kim Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
18,600
-3.65%
|
$260,400
$14.54 P/Share
|
|
Jul 31
2025
|
Christopher J Joyce Chief Legal and Admin. Officer |
SELL
Open market or private sale
|
Direct |
15,491
-3.97%
|
$247,856
$16.01 P/Share
|
|
Jul 31
2025
|
Joseph S Konowiecki Director |
SELL
Open market or private sale
|
Direct |
25,000
-2.12%
|
$400,000
$16.0 P/Share
|
|
Jul 14
2025
|
Dawn Christine Maroney President |
SELL
Open market or private sale
|
Direct |
30,000
-1.45%
|
$390,000
$13.44 P/Share
|
|
Jul 10
2025
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
180,000
-10.39%
|
$2,340,000
$13.41 P/Share
|
|
Jun 16
2025
|
Dawn Christine Maroney President |
SELL
Open market or private sale
|
Direct |
30,000
-1.43%
|
$420,000
$14.48 P/Share
|
|
Jun 16
2025
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
90,000
-4.94%
|
$1,260,000
$14.48 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 6.65M shares |
|---|
| Open market or private sale | 66.1M shares |
|---|---|
| Bona fide gift | 43.6K shares |